Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheeba Alam

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Vaccines|July 14, 2010
DNA vaccines for the treatment of prostate cancerSheeba Alam, Douglas G McNeel
Vaccine|November 6, 2007
Catalytically inactive anthrax toxin(s) are potential prophylactic agentsMegha Gupta, Sheeba Alam, Rakesh Bhatnagar
Archives of Biochemistry and Biophysics|January 3, 2006
Kinetic characterization and ligand binding studies of His351 mutants of Bacillus anthracis adenylate cyclaseMegha Gupta, Sheeba Alam, Rakesh Bhatnagar
Biochemical and Biophysical Research Communications|November 19, 2005
Inhibition of platelet aggregation by anthrax edema toxinSheeba Alam, Megha Gupta, Rakesh Bhatnagar
Biochemical and Biophysical Research Communications|August 2, 2003
Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivoNidhi Ahuja, Praveen Kumar, Sheeba Alam, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2012
Memory T cells are uniquely resistant to melanoma-induced suppressionLucy Wentworth, Justin V Meyers, Sheeba Alam, et al.
Cellular Immunology|July 12, 2011
Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansionAndrew J Russ, Kyle Xu, Lucy Wentworth, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|July 14, 2010
DNA vaccines for the treatment of prostate cancerSheeba Alam, Douglas G McNeel
Vaccine|November 6, 2007
Catalytically inactive anthrax toxin(s) are potential prophylactic agentsMegha Gupta, Sheeba Alam, Rakesh Bhatnagar
Archives of Biochemistry and Biophysics|January 3, 2006
Kinetic characterization and ligand binding studies of His351 mutants of Bacillus anthracis adenylate cyclaseMegha Gupta, Sheeba Alam, Rakesh Bhatnagar
Biochemical and Biophysical Research Communications|November 19, 2005
Inhibition of platelet aggregation by anthrax edema toxinSheeba Alam, Megha Gupta, Rakesh Bhatnagar
Biochemical and Biophysical Research Communications|August 2, 2003
Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivoNidhi Ahuja, Praveen Kumar, Sheeba Alam, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2012
Memory T cells are uniquely resistant to melanoma-induced suppressionLucy Wentworth, Justin V Meyers, Sheeba Alam, et al.
Cellular Immunology|July 12, 2011
Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansionAndrew J Russ, Kyle Xu, Lucy Wentworth, et al.
Pageof 1